GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Fgf21 | increases expression | EXP | | 6480464 | CTD | Thapsigargin results in increased expression of FGF21 mRNA | PMID:23123503 | Fgf21 | increases secretion | EXP | | 6480464 | CTD | Thapsigargin results in increased secretion of FGF21 protein | PMID:23123503 | Fgf21 | increases expression | ISO | FGF21 (Homo sapiens) | 6480464 | CTD | Thapsigargin results in increased expression of FGF21 mRNA | PMID:23123503 | Fgf21 | increases expression | ISO | Fgf21 (Mus musculus) | 6480464 | CTD | Thapsigargin results in increased expression of FGF21 mRNA | PMID:27226639 | Fgf21 | multiple interactions | ISO | Fgf21 (Mus musculus) | 6480464 | CTD | indolo(3,2-b)carbazole inhibits the reaction [Thapsigargin results in increased expression of FGF21 mRNA]; N-(2-(3H-indol-3-yl)ethyl)-9-isopropyl-2-(5-methyl-3-pyridyl)purin-6-amine inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Thapsigargin results in increased expression of FGF21 mRNA]]; Tetrachlorodibenzodioxin inhibits the reaction [Thapsigargin results in increased expression of FGF21 mRNA] | PMID:27226639 | |
Go Back to source page | Continue to Ontology report |